BioCentury
ARTICLE | Financial News

Five Prime sets IPO range

September 5, 2013 12:05 AM UTC

Five Prime Therapeutics Inc. (South San Francisco, Calif.) amended its IPO and now plans sell 4 million shares at $12-$14. At the $13 midpoint, the company would raise $52 million and be valued at $197.8 million. Five Prime filed to raise up to $60 million in an IPO in July. Jefferies; BMO Capital Markets; Wells Fargo; and Guggenheim Securities are underwriters. ...